PREOPEN CAC 40: 8,134 points (+0.26%)
Key Stocks of the Day
Sanofi (SAN): Its drug Efdoralprin receives orphan drug designation from the European Medicines Agency (EMA).
Pernod Ricard (RI): Announces the sale of Mumm Napa sparkling wines to Trinchero; definitive agreement reached.
DBV Technologies (DBV): Successful clinical trial for its peanut allergy treatment. FDA marketing application planned.
Vinci (DG): Highway traffic declined in November, but notable rise (+5.9%) at airports.
Airports of Paris (ADP): Strong passenger traffic growth in November (+5.9%).
Euroapi (EAPI): Expects a greater drop in revenue in 2025.
Plastivaloire (PVL): Forecasts a slight revenue decline for 2025-2026.
Abionyx (ABNX): Launching a €1.8M capital increase to fund development through 2026.
Implanet (ALIMP): First surgeries performed in China with its JAZZ system.
Voltalia (VLTSA): Launches the construction of a hybrid solar power plant in French Guiana.
Crédit Agricole (ACA): Éric Vial elected chairman of the board.
Bic (BB): Karen Guerra appointed to the board to replace Carole Callebaut Piwnica.
Company Results Expected Today
(No major results reported at this time)
Analyst Recommendations (France only)
Upgrades
DBV Technologies (DBV)
→ Cantor Fitzgerald remains at overweight, target raised from USD 42 to 48.
→ Guggenheim remains at buy, target raised from USD 35 to 51.
Abivax (ABVX)
→ Leerink Partners remains at outperform, target raised from USD 115 to 138.
→ Piper Sandler remains at overweight, target raised from USD 112 to 142.
Eurofins Scientific (ERF)
→ Bernstein remains at outperform, target adjusted to EUR 72.30.
Neutral
Arkema (AKE)
→ UBS maintains buy but cuts target from EUR 70 to 64.
Airports of Paris (ADP)
→ Jefferies moves from buy to hold, despite a raised target of EUR 134.
Pernod Ricard (RI)
→ Deutsche Bank remains at hold, target reduced from EUR 80 to 75.
→ Morgan Stanley remains at underweight, target reduced from EUR 84 to 80.
Sartorius Stedim Biotech (DIM)
→ Bernstein remains at outperform, target slightly reduced from EUR 248 to 245.
Solvay (SOLB)
→ UBS remains at neutral, target adjusted to EUR 28.
Downgrades
No major downgrades reported for French stocks this morning.
